Clinical trials
Immune System Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 8 |
| Terminated | 4 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 3 |
| GlaxoSmithKline | 2 |
| Pfizer | 2 |
| Takeda | 2 |
| AstraZeneca | 1 |
| Beeline Medicines Corporation | 1 |
| Beijing Tiantan Hospital | 1 |
| Biogen | 1 |
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 32 |
| Autoimmune Diseases | 16 |
| Hematologic Diseases | 6 |
| Connective Tissue Diseases | 5 |
| Endocrine System Diseases | 5 |
| Hemorrhagic Disorders | 4 |
| Metabolic Diseases | 4 |
| Neoplasms | 4 |
| Cardiovascular Diseases | 3 |
| Dermatitis | 3 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.